Lilly says Mounjaro and Zepbound sales grew by at least 110% as stock rallies
The drugmaker also detailed strong growth for 2026
Business & Finance
Stay informed with expert takes on business strategy, investing, entrepreneurship, and global markets. CurioAtlas brings you articles that guide smarter decisions in finance and business growth.
HMRC charges £325m in penalties for late self-assessment payments
Post Content
Forvis Mazars appoints partner for audit quality enablement and operations
Post Content
Palantir (PLTR) Delivers Another ‘Drop-the-Mic’ Quarter, Wedbush Says
Post Content
Columbia Sportswear FY earnings beat forecasts amid ongoing US challenges
Post Content
Tax Planners: Costliest Mistakes the Middle-Class Makes on Their Taxes
Post Content
Amazon.com’s (AMZN) 2026 Could Mark an AI Script Flip, Evercore Says
Post Content
UBS Cuts Oracle (ORCL) Target but Sees Funding Clarity as a Catalyst
Post Content
Why Cantor Is Sticking With Tesla (TSLA) on AI and Robotics
Post Content
This Could Be the Easiest Way to Get Tax-Free Income in Retirement
Post Content